Keratin Biosciences   Report issue

For profit
Founded: Winston-Salem NC United States (2008)

Organization Overview

First Clinical Trial
2019
NCT04058054
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

KeraNetics, LLC

Active Ingredients

Drugs in Other Trials (2)

histamine (1 trial)

sodium chloride (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2